z-logo
open-access-imgOpen Access
Degenerative Mitral Stenosis
Author(s) -
Karan Sud,
Shikhar Agarwal,
Akhil Parashar,
Mohammad Q. Raza,
Kunal Patel,
David Min,
Leonardo Rodríguez,
Amar Krishnaswamy,
Stephanie L. Mick,
A. Marc Gillinov,
E. Murat Tuzcu,
Samir Kapadia
Publication year - 2016
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.115.020185
Subject(s) - medicine , stenosis , percutaneous , mitral valve , life expectancy , intensive care medicine , epidemiology , cardiology , mitral valve stenosis , surgery , population , environmental health
Degenerative mitral stenosis (DMS) is an important cause of mitral stenosis, developing secondary to severe mitral annular calcification. With the increase in life expectancy and improved access to health care, more patients with DMS are likely to be encountered in developed nations. These patients are generally elderly with multiple comorbidities and often are high-risk candidates for surgery. The mainstay of therapy in DMS patients is medical management with heart rate control and diuretic therapy. Surgical intervention might be delayed until symptoms are severely limiting and cannot be managed by medical therapy. Mitral valve surgery is also challenging in these patients because of the presence of extensive calcification. Hence, there is a need to develop an alternative percutaneous treatment approach for patients with DMS who are otherwise inoperable or at high risk for surgery. In this review, we summarize the available data on the epidemiology of DMS and diagnostic considerations and current treatment strategies for these patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom